Pemvidutide

DB18998InvestigationalProtein Based Therapies

Pemvidutide is under investigation in clinical trial NCT05989711 (Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH) (IMPACT Trial)).

Code names
MD-1373 · SP-1373

Resolves to

Compound
UNIIA35F525WBGCAS2538014-94-5
Targets
P43220GLP1RP47871GCGR

What you can answer from here — as of September 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Pemvidutide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In